logo
Plus   Neg
Share
Email

LendingTree Increases Full-year Guidance - Quick Facts

LendingTree, Inc. (TREE) announced, for 2018, adjusted EBITDA is now anticipated in the range of $152 - $155 million, up from prior range of $148 - $152 million, and representing growth of 32% - 35% over 2017. Revenue is now anticipated to be in the range of $765 - $775 million, up from prior range of $745 - $765 million.

For the third-quarter, adjusted EBITDA was $45.3 million increased 31% over third quarter 2017. Consolidated revenue was $197.1 million, an increase of 15% over revenue in the third quarter 2017.

J.D. Moriarty, CFO, said: "Although the mortgage environment continues to worsen, our other businesses are picking up the slack, enabling us to stay focused on enhancing the mortgage experience. And with the QuoteWizard acquisition officially closed as of yesterday, we're thrilled to be a leading player, at scale, in yet another large and growing non-mortgage category. We continue to meet our financial commitments, we're increasing our full-year guidance to reflect the impact of the acquisition."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Video streaming giant Netflix said it will donate 1 million euros to Audiens, the social protection group of the French cultural sector, to help launch a COVID-19 emergency relief fund to support workers in the French television and cinema industry. Netflix and Audiens said they have created the new COVID-19 Film and TV Emergency Relief Fund to help the hardest hit workers in the industry. Major U.S. retail container ports are estimated to report a five-year low for imports in March as consumer demand has been impacted with millions of Americans out of work amid the coronavirus (COVID-19) outbreak, according to a report by the National Retail Federation or NRF. The U.S. Food and Drug Administration has issued warning letters to three sellers of fraudulent COVID-19 products. There are currently no approved preventatives or treatments for COVID-19, the FDA said in a statement.
Follow RTT
>